IMA vs LOW · rev $9.2M vs P/E 18, rev $86.29B
ImageneBio, Inc. (IMA) versus Lowe's Companies Inc (LOW) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Lowe's Companies Inc (LOW) is a home improvement retail company listed on NYSE.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
Latest reported LOW revenue for 2026-01-30 was $86.29B. Net income was $6.65B. Revenue was up 3.1% from 2025-01-31 to 2026-01-30. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
IMA currently screens at market cap $64.7M. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
Not investment advice. Open the IMA and LOW stock pages for the full models.
Not investment advice.